A Quantitative Approach to the Estimation of Chemical Space from a Given Geometry by the Combination of Atomic Species
暂无分享,去创建一个
Hiroshi Yamashita | Tetsu Isomura | Hiroshi Yamashita | K. Ogata | Tetsu Isomura | H. Kubodera | Koji Ogata | Hideo Kubodera
[1] N. Cohen,et al. The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses. , 1993, Journal of medicinal chemistry.
[2] Akiko Itai,et al. Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation , 1991 .
[3] Tudor I. Oprea,et al. Chemical space navigation in lead discovery. , 2002, Current opinion in chemical biology.
[4] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[5] G. Rishton. Nonleadlikeness and leadlikeness in biochemical screening. , 2003, Drug discovery today.
[6] Jürgen Bajorath,et al. Molecular Descriptors for Effective Classification of Biologically Active Compounds Based on Principal Component Analysis Identified by a Genetic Algorithm , 2000, J. Chem. Inf. Comput. Sci..
[7] S. Paula,et al. Molecular determinants of thapsigargin binding by SERCA Ca2+‐ATPase: A computational docking study , 2004, Proteins.
[8] Jürgen Bajorath,et al. Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.
[9] Lars Hemmingsen,et al. Docking and scoring of metallo-β-lactamases inhibitors , 2004, J. Comput. Aided Mol. Des..
[10] Tudor I. Oprea,et al. Pursuing the leadlikeness concept in pharmaceutical research. , 2004, Current opinion in chemical biology.
[11] Gang Chen,et al. A New Rapid and Effective Chemistry Space Filter in Recognizing a Druglike Database , 2005, J. Chem. Inf. Model..
[12] Regine Bohacek,et al. Multiple Highly Diverse Structures Complementary to Enzyme Binding Sites: Results of Extensive Application of a de Novo Design Method Incorporating Combinatorial Growth , 1994 .
[13] P. Kollman,et al. An all atom force field for simulations of proteins and nucleic acids , 1986, Journal of computational chemistry.
[14] Tudor I. Oprea. Current trends in lead discovery: Are we looking for the appropriate properties? , 2002, J. Comput. Aided Mol. Des..
[15] P Willett,et al. Docking small-molecule ligands into active sites. , 1995, Current opinion in biotechnology.
[16] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[17] Daniel A. Gschwend,et al. Orientational sampling and rigid‐body minimization in molecular docking , 1993, Proteins.
[18] A Itai,et al. Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation. , 1993, Journal of medicinal chemistry.
[19] Gordon M. Crippen,et al. Prediction of Physicochemical Parameters by Atomic Contributions , 1999, J. Chem. Inf. Comput. Sci..
[20] Hans-Joachim Böhm,et al. LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads , 1992, J. Comput. Aided Mol. Des..
[21] Eugene I. Shakhnovich,et al. SMOG : DE NOVO DESIGN METHOD BASED ON SIMPLE, FAST, AND ACCURATE FREE ENERGY ESTIMATES. 2. CASE STUDIES IN MOLECULAR DESIGN , 1997 .
[22] Hans-Joachim Böhm,et al. The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure , 1994, J. Comput. Aided Mol. Des..
[23] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[24] Tudor I. Oprea,et al. Chemography: the Art of Navigating in Chemical Space , 2000 .
[25] A. Hawkins,et al. Structure-based design, synthesis, and biological evaluation of inhibitors of Mycobacterium tuberculosis type II dehydroquinase. , 2005, Journal of medicinal chemistry.
[26] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[27] D K Gehlhaar,et al. De novo design of enzyme inhibitors by Monte Carlo ligand generation. , 1995, Journal of medicinal chemistry.